IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
pharma pay-for-delay agreements
From:
Sylvia Caras <[log in to unmask]>
Reply To:
[log in to unmask]
Date:
Sun, 8 Feb 2009 12:30:28 -0800
Content-Type:
text/plain
Parts/Attachments:
text/plain (15 lines) 
"The FTC has twice sought to persuade the Supreme Court to consider 
cases challenging pay-for-delay agreements, but both cases were 
turned away.   ...  But society also has a strong interest in making 
sure that generic drugs become available as soon as legally 
appropriate.  ...  At this point, there's little to be gained, at 
least for consumers, from backroom deals made by interested corporate 
parties."

<http://www.latimes.com/news/opinion/editorials/la-ed-ftc5-2009feb05,0,5897259.story>http://www.latimes.com/news/opinion/editorials/la-ed-ftc5-2009feb05,0,5897259.story 




Powered by LSoft's LISTSERV(R) list management software

ATOM RSS1 RSS2